Gustavo B F Oliveira
Overview
Explore the profile of Gustavo B F Oliveira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leong D, Fradet V, Niazi T, Selvanayagam J, Sabbagh R, Higano C, et al.
JACC CardioOncol
. 2024 Oct;
6(5):761-771.
PMID: 39479325
Background: There are limited data on the physical effects of androgen deprivation therapy (ADT) for prostate cancer (PC), and on the relationships of such measures of adiposity and strength to...
2.
Avezum A, Oliveira Junior H, Neves P, Alves L, Cavalcanti A, Rosa R, et al.
EClinicalMedicine
. 2023 May;
60:102004.
PMID: 37223666
Background: COVID-19 progression is associated with an increased risk of arterial and venous thrombosis. Randomised trials have demonstrated that anticoagulants reduce the risk of thromboembolism in hospitalised patients with COVID-19,...
3.
Oliveira G, Neves P, Oliveira H, Mangas Catarino D, Alves L, Cavalcanti A, et al.
Arq Bras Cardiol
. 2023 Apr;
120(3):e20220431.
PMID: 37018790
Background: Previous studies have demonstrated a high risk of arterial and venous thromboembolic events as a consequence of direct viral damage to endothelial cells by SARS-CoV-2 and a procoagulant milieu...
4.
Avezum A, Oliveira G, Oliveira H, Lucchetta R, Pereira V, Dabarian A, et al.
Lancet Reg Health Am
. 2022 Apr;
11:100243.
PMID: 35378952
Background: Previous Randomised controlled trials (RCT) evaluating chloroquine and hydroxychloroquine in non-hospitalised COVID-19 patients have found no significant difference in hospitalisation rates. However, low statistical power precluded definitive answers. Methods:...
5.
de Oliveira Junior H, Ferri C, Boszczowski I, Oliveira G, Cavalcanti A, Rosa R, et al.
Arq Bras Cardiol
. 2022 Mar;
118(2):378-387.
PMID: 35262569
Background: Despite the need for targeting specific therapeutic options for coronavirus disease 2019 (COVID-19), there has been no evidence of effectiveness of any specific treatment for the outpatient clinical setting....
6.
Martines D, Nii F, Medeiros K, Carvalho B, Pipek L, de Mesquita G, et al.
Sci Rep
. 2020 Sep;
10(1):15499.
PMID: 32968193
The number of non-cardiac major surgeries carried out has significantly increased in recent years to around 200 million procedures carried out annually. Approximately 30% of patients submitted to non-cardiac surgery...
7.
Dagenais G, Leong D, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, et al.
Lancet
. 2019 Sep;
395(10226):785-794.
PMID: 31492501
Background: To our knowledge, no previous study has prospectively documented the incidence of common diseases and related mortality in high-income countries (HICs), middle-income countries (MICs), and low-income countries (LICs) with...
8.
Roever L, Resende E, Diniz A, Penha-Silva N, OConnell J, Gomes P, et al.
Medicine (Baltimore)
. 2018 Jun;
97(24):e11094.
PMID: 29901625
Introduction: The prevalence of metabolic syndrome (MetS) and MetS-related stroke is set to increase dramatically in coming decades. MetS is a complex disease that includes endothelial dysfunction, insulin resistance, diabetes,...
9.
Roever L, Resende E, Diniz A, Penha-Silva N, OConnell J, Gomes P, et al.
Medicine (Baltimore)
. 2018 Apr;
97(17):e0273.
PMID: 29702973
Background: Atherosclerosis is now widely recognized as a multifactorial disease with outcomes that arise from complex factors such as plaque components, blood flow, and inflammation. Epicardial adipose tissue (EAT) is...
10.
Roever L, Resende E, Diniz A, Penha-Silva N, OConnell J, Gomes P, et al.
Medicine (Baltimore)
. 2018 Apr;
97(16):e0387.
PMID: 29668593
Background: The prevalence of metabolic syndrome (MetS) and MetS-related stroke is set to increase dramatically in coming decades. MetS is a complex disease that includes endothelial dysfunction, insulin resistance, diabetes,...